Trial intelligence / Profile preview

Vitamin K and Bone Turnover in Postmenopausal Women

NCT00062595Phase 3Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Sep 2000
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of phytomenadione, menatetrenone in osteoporosis, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Sep 2000; status: completed.

02

Drugs

phytomenadionemenatetrenone
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT00062595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00062595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call